NCT01124045View on ClinicalTrials.gov

Difluprednate Pediatric Study for the Treatment of Inflammation Post-Cataract Surgery

PHASE3CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2012

Conditions
CataractsInflammation
Interventions
DRUG

Difluprednate ophthalmic emulsion, 0.05%

Topical ocular administration

DRUG

Prednisolone acetate ophthalmic suspension, 1.0%

Topical ocular administration

Trial Locations (1)

76134

Contact Alcon Call Center For Trial Locations, Fort Worth

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY